HIV in Europe started in Brussels in 2007 with a pan-European conference entitled “HIV in Europe 2007: Working together for optimal testing and earlier care". Since then, the biennial HIV in Europe conferences have been an important component of the unique European initative.
On 28 January 2019, the initiative was officially renamed as EuroTEST with the intention of broadening the disease scope of the initiative to address hepatitis, HIV, sexually transmitted infections (STIs) and tuberculosis (TB). EuroTEST aims to utilise integrated strategies to help increase early detection and earlier entry into treatment leading to better health outcomes and preventing the risk of further transmission. Directed by an extensive and independent group of experts with representation from civil society, policy makers, health professionals and European public health institutions, the initiative is truly a multi-disciplinary and pan-European collaboration.
EuroTEST is an initiative formed to inform policy-making/implementation, knowledge sharing, and to improve the evidence base on important issues related to earlier testing and care. It is unique in its collaboration between stakeholders from both clinical, advocacy and public health policy levels, who all share the common objective of ensuring earlier detection of HIV, viral hepatitis, STIs and TB.
To read the complete history of the initiative, please read the 10-year anniversary booklet published in 2017.